Research ArticleArticle
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano, Luciana Pierro, Ilenia Pantano, Michele Iudici and Gabriele Valentini
The Journal of Rheumatology May 2017, jrheum.161351; DOI: https://doi.org/10.3899/jrheum.161351
Serena Fasano
From the Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, Naples, Italy. S. Fasano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; L. Pierro, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; I. Pantano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; M. Iudici, PhD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; G. Valentini, Professor, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples. Address correspondence to Dr. S. Fasano, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, II Policlinico, Via S. Pansini 5, Building 3, 80131 Naples, Italy. E-mail: serefasa@gmail.com. Accepted for publication March 22, 2017.
Luciana Pierro
From the Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, Naples, Italy. S. Fasano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; L. Pierro, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; I. Pantano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; M. Iudici, PhD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; G. Valentini, Professor, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples. Address correspondence to Dr. S. Fasano, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, II Policlinico, Via S. Pansini 5, Building 3, 80131 Naples, Italy. E-mail: serefasa@gmail.com. Accepted for publication March 22, 2017.
Ilenia Pantano
From the Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, Naples, Italy. S. Fasano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; L. Pierro, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; I. Pantano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; M. Iudici, PhD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; G. Valentini, Professor, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples. Address correspondence to Dr. S. Fasano, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, II Policlinico, Via S. Pansini 5, Building 3, 80131 Naples, Italy. E-mail: serefasa@gmail.com. Accepted for publication March 22, 2017.
Michele Iudici
From the Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, Naples, Italy. S. Fasano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; L. Pierro, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; I. Pantano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; M. Iudici, PhD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; G. Valentini, Professor, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples. Address correspondence to Dr. S. Fasano, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, II Policlinico, Via S. Pansini 5, Building 3, 80131 Naples, Italy. E-mail: serefasa@gmail.com. Accepted for publication March 22, 2017.
Gabriele Valentini
From the Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, Naples, Italy. S. Fasano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; L. Pierro, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; I. Pantano, MD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; M. Iudici, PhD, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples; G. Valentini, Professor, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples. Address correspondence to Dr. S. Fasano, Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, II Policlinico, Via S. Pansini 5, Building 3, 80131 Naples, Italy. E-mail: serefasa@gmail.com. Accepted for publication March 22, 2017.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano, Luciana Pierro, Ilenia Pantano, Michele Iudici, Gabriele Valentini
The Journal of Rheumatology May 2017, jrheum.161351; DOI: 10.3899/jrheum.161351
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano, Luciana Pierro, Ilenia Pantano, Michele Iudici, Gabriele Valentini
The Journal of Rheumatology May 2017, jrheum.161351; DOI: 10.3899/jrheum.161351